相关实验视频
Updated: Jun 11, 2026

07:02
In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
一个MicroRNA准分辨器用于转移控制
Graziano Martello1, Antonio Rosato, Francesco Ferrari
1Department of Histology, Microbiology and Medical Biotechnologies, University of Padua School of Medicine, viale Colombo 3, 35126 Padua, Italy.
Cell
|July 7, 2010
概括
高水平的microRNAs (miRNAs),特别是miR-103/107,通过向Dicer并诱导上皮细胞到介质细胞过渡 (EMT),促进癌症转移. 抑制这些miRNA可以减少癌细胞的迁移和扩散.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 基因法规 基因法规
背景情况:
- 全球微RNA (miRNA) 下调在人类癌症中很常见,但其机制和益处尚不清楚.
- 微RNAs调节基因表达,在癌症的发展和进展中至关重要.
研究的目的:
- 为了确定参与癌症全球miRNA下调的miRNAs.
- 调查miR-103/107在癌症转移和上皮细胞转移到介质细胞转移 (EMT) 中的作用.
主要方法:
- 确定了针对Dicer的miR-103/107,这是miRNA生物合成中的关键酶.
- 在人类乳腺癌组织中分析miR-103/107水平.
- 在体外和体内实验中评估miR-103/107对细胞迁移和转移的功能影响.
- 研究miR-103/107对miR-200水平和EMT诱导的影响.
主要成果:
- miR-103/107直接向并减弱Dicer,从而降低了整体miRNA生物合成.
- 升高的miR-103/107水平与乳腺癌患者的转移和不良预后相关.
- 过度表达miR-103/107增强了体外癌细胞迁移,并在体内促进转移.
- 抑制miR-103/107可以抑制癌细胞迁移和转移.
- miR-103/107通过降低miR-200家族成员的调节来诱导EMT.
结论:
- 通过Dicer抑制和EMT诱导,miR-103/107家族在促进癌症转移方面发挥着至关重要的作用.
- 向miR-103/107提供了一种潜在的治疗策略,可以对抗癌症转移.
- 这项研究揭示了一个新的机制,将miRNA失调与癌症进展和侵袭性联系起来.
相关概念视频
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
MicroRNAs
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
